EudraLex - Volume 1 - Pharmaceutical Legislation
Medicinal Products for Human Use

Volume 1 of the publications "The rules governing medicinal products in the European Union" compiles the body of European Union legislation in the pharmaceutical sector for medicinal products for human use.

On this page :

Directives
2001/83/EC Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (Consolided version : 21/07/2011).
български
češtin
dansk
2012/26/EU Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012
amending Directive 2001/83/EC as regards pharmacovigilance (Text with EEA relevance) (OJ L 299, 27.10.2012, p. 1–4)
български
češtin
dansk
2011/62/EC Directive 2011/62/EU of the European Parliament and of the Council  of  8 June 2011
amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products.
български
češtin
dansk
2010/84/EC

Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. (Official Journal L 348, 31/12/2010, p.†74 - 99).

български
češtin
dansk
Corrigendum

Corrigendum (Official Journal L 21, 25/1/2011 p. 8).

български
češtin
dansk
2009/53/EC Directive 2009/53/EC of the European Parliament and of the Council of 18 June 2009 amending Directive 2001/82/EC and Directive 2001/83/EC, as regards variations to the terms of marketing authorisations for medicinal products. (Official Journal L 168, 30/6/2009, p. 33 - 34).
български
češtin
dansk
Corrigendum Corrigendum to Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use ( OJ L 348, 31.12.2010)
български
češtin
dansk

2002/98/EC

Amended by Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC (Official Journal L 33, 8/2/2003 p. 30 - 40).

български
češtin
dansk

 

Corrigendum (Official Journal L 230, 24/8/2006 p. 12 PL).

2003/63/EC

Amended by Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Official Journal L 159, 27/6/2003 p. 46 - 94).

български
češtin
dansk

 

Corrigendum (Official Journal L 302, 20/11/2003 p. 40 DE).

2004/24/EC

Amended by Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use (Official Journal L 136, 30/4/2004, p. 85 - 90).

български
češtin
dansk

2004/27/EC

Amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use (Official Journal L 136, 30/4/2004 p. 34 - 57).

български
češtin
dansk

2008/29/EC

Amended by Directive 2008/29/EC of the European Parliament and of the Council of 11 March 2008 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the implementing powers conferred on the Commission (Official Journal L 81, 20/3/2008, p. 51 - 52 ).

български
češtin
dansk

2009/120/EC

Amended by Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products (Official Journal L 242 15/9/2009, p. 3 - 12).

български
češtin
dansk
2001/20/EC Directive 2001/20/EC OF the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (Official Journal L 121, 1/5/2001 p. 34 - 44).
български
češtin
dansk
Corrigendum (Official Journal L 300, 5/11/2002 p. 58 - 58 NL).
2003/94/EC Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (Official Journal L 262, 14/10/2003 p. 22 - 26).
български
češtin
dansk
2005/28/EC Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products (Official Journal L 91, 9/4/2005 p. 13 - 19 ).
български
češtin
dansk
89/105/EEC Council Directive 89/105/EEC, of 21 December 1988, relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion within the scope of national health insurance systems (Official Journal L 40, 11/2/1989 p. 8 - 11; Finnish special edition: Chapter 15 Volume 9 p. 45; Swedish special edition: Chapter 15 Volume 9 p. 45).
češtin
dansk
Regulations
EC/726/2004 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Consolided version : 20/04/2009, Lithuanian Consolidadted version 02/07/2012).
български
češtin
dansk
2012/1027/EU Regulation (EU) no 1027/2012 of the european parliament and of the council of 25 october 2012 amending regulation (EC) no 726/2004 as regards pharmacovigilance. (OJ L 316, 14.11.2012, p. 38-40)
български
češtin
dansk
2010/1235/EU Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products Text with EEA relevance (OJ L 348, 31.12.2010, p. 1–16)
български
češtin
dansk
Corrigendum Corrigendum to Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance of medicinal products for human use, Regulation (EC) No 726/2004 laying down Community procedures forthe authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, and Regulation (EC) No 1394/2007 on advanced therapy medicinal products ( OJ L 348, 31.12.2010)
български
češtin
dansk
2009/219/EC

Amended by Regulation (EC) No 219/2009 of the European Parliament and of the Council of 11 March 2009 adapting a number of instruments subject to the procedure referred to in Article 251 of the Treaty to Council Decision 1999/468/EC with regard to the regulatory procedure with scrutiny Adaptation to the regulatory procedure with scrutiny - Part Two (Official Journal L 87, 231/3/2009, p. 109 - 154, especially p. 116 - 118, Annex 2.9, where Regulation (EC) No 726/2004 is adapted).

български
češtin
dansk
EC/297/95 Council Regulation (EC) No 297/95, of 10 February 1995, on fees payable to the European Agency for the Evaluation of Medicinal Products (Official Journal L 35, 15/2/1995 p. 1 - 5).
български
češtin
dansk
Corrigendum (Official Journal L 75, 4/4/1995 p. 29.
ES DA DE EL EN FR IT NL PT FI SV).
dansk

EC/2743/98 

Council Regulation (EC) No 2743/98 of 14 December 1998 amending Regulation (EC) No 297/95 on fees payable to the European Agency for the Evaluation of Medicinal Products (Official Journal L 345, 19/12/1998 p 3 - 8).

български
češtin
dansk

EC/494/2003

Commission Regulation (EC) No 494/2003 of 18 March 2003 amending Council Regulation (EC) No 297/95 on the fees payable to the European Agency for the Evaluation of Medicinal Products (Official Journal L 73, 19/3/2003 p. 6 - 7)

български
češtin
dansk

EC/1905/2005

Council Regulation (EC) No 1905/2005, of 14 November 2005, amending Regulation (EC) No 297/95 on fees payable to the European Medicines Agency (Official Journal L 340, 13/11/2005 p. 1 - 9)

български
češtin
dansk

EC/312/2008

Commission Regulation (EC) No 312/2008 of 3 April 2008 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate

bg
cs
da
de
el
en
es
et
fi
fr
hu
it
lt
lv
mt
nl
pl
pt
ro
sk
sl
sv

EC/249/2009

Commission Regulation (EC) No 249/2009 of 23 March 2009 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate (Official Journal L 79, 25/3/2009 p. 34 - 36)

bg
cs
da
de
el
en
es
et
fi
fr
hu
it
lt
lv
mt
nl
pl
pt
ro
sk
sl
sv
EU/261/2010 Commission Regulation (EU) No 261/2010 of 25 March 2010 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate
(OJ L 80, 26.3.2010, p. 36–39)
български
češtin
dansk
EU/301/2011 Commission Regulation (EU) No 301/2011 of 28 March 2011 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation.
Text with EEA relevance
(OJ L 81, 29.3.2011, p. 5–7)
български
češtin
dansk
EU/273/2012 Commission Regulation (EU) No 273/2012 of 27 March 2012 amending Council Regulation (EC) No 297/95 as regards the adjustment of the fees of the European Medicines Agency to the inflation rate Text with EEA relevance (OJ L 90, 28.3.2012, p. 11–13)
български
češtin
dansk
EC/540/95 Commission Regulation (EC) No 540/95, of 10 March 1995, laying down the arrangements for reporting suspected unexpected adverse reactions which are not serious, whether arising in the Community or in a third country, to medicinal products for human or veterinary use authorized in accordance with the provisions of Council Regulation (EEC) No 2309/93 (Official Journal L 55, 11/3/1995 p. 5 - 6).
български
češtin
dansk
EC/1662/95 Commission Regulation (EC) No 1662/95, of 7 July 1995, laying down certain detailed arrangements for implementing the Community decision-making procedures in respect of marketing authorizations for products for human or veterinary use (Official Journal L 158, 8/7/1995 p. 4 - 5).
български
češtin
dansk
Corrigendum (Official Journal L 249, 17/10/1995 p. 47 PT).
EC/2141/96 Commission Regulation (EC) No 2141/96, of 7 November 1996, concerning the examination of an application for the transfer of a marketing authorization for a medicinal product falling within the scope of Council Regulation (EEC) No 2309/93 (Official Journal L 286, 8/11/1996 p. 6 - 8).
български
češtin
dansk

EC/141/2000

Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (Official Journal L 18, 22/1/2000 p. 1 - 5).

български
češtin
dansk
EC/847/2000 Commission Regulation (EC) No 847/2000 of 27 April 2000 laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts ‘similar medicinal product’ and‘clinical superiority’ (Official Journal L 103, 28/4/2000 p. 5 - 8).
български
češtin
dansk
EC/2049/2005 Commission Regulation (EC) No 2049/2005, of 15 December 2005, laying down, pursuant to Regulation (EC) No 726/2004 of the European Parliament and of the Council, rules regarding the payment of fees to, and the receipt of administrative assistance from, the European Medicines Agency by micro, small and medium-sized enterprises (Official Journal L 329, 16/12/2005 p. 4 - 7).
български
češtin
dansk
EC/507/2006 Commission Regulation (EC) No 507/2006 of 29 March 2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726/2004 of the European Parliament and of the Council (Official Journal L 92, 30/3/2006 p. 6 - 9).
български
češtin
dansk
EC/1901/2006 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004
български
češtin
dansk
EC/1902/2006 Regulation (EC) No 1902/2006 of the European Parliament and of the Council of 20 December 2006 amending Regulation 1901/2006 on medicinal products for paediatric use
češtin
dansk
EC/658/2007 Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties for infringement of certain obligations in connection with marketing authorisations granted under Regulation (EC) No 726/2004 of the European Parliament and of the Council (Official Journal L 155, 15/6/2007 p. 10 - 19).
български
češtin
dansk
EU/488/2012 Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/2007 concerning financial penalties for infringement of certain obligations in connection with marketing authorisations granted under Regulation (EC) No 726/2004 of the European Parliament and of the Council (Official Journal L 150, 9/6/2012, p. 68–70)
български
češtin
dansk
Corrigendum Corrigendum to Commission Regulation (EU) No 488/2012 (Official Journal L 338, 12/12/2012, p. 44)
български
češtin
dansk
EC/1394/2007 Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Note: shall apply from 30 December 2008)(Official Journal L 324, 10/12/2007 p. 121 - 137).
български
češtin
dansk
EC/1234/2008 Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Official Journal L 334, 12/12/2008 p. 7 - 24).
български
češtin
dansk
Consolidated version : 2.11.2012
български
češtin
dansk
EC/712/2012 Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (Official Journal L 209, 4/8/2012, p. 4 - 14).
български
češtin
dansk
EC/688/2009 Commission Regulation (EC) No 668/2009 of 24 July 2009 implementing Regulation (EC) No 1394/2007 of the European Parliament and of the Council with regard to the evaluation and certification of quality and non-clinical data relating to advanced therapy medicinal products developed by micro, small and medium-sized enterprises (Official Journal L 194, 25/7/2009 p. 7 - 10).
български
češtin
dansk
Miscellaneous
75/320/EEC Council Decision 75/320/EEC, of 20 May 1975, setting up a Pharmaceutical Committee (Official Journal L 147, 9/6/1975 p. 23; Spanish special edition: Chapter 13 Volume 4 p. 102; Portuguese special edition: Chapter 13 Volume 4 p. 102; Finnish special edition: Chapter 13 Volume 4 p. 108 Swedish special edition: Chapter 13 Volume 4 p. 108).
български
češtin
dansk
Corrigendum (Official journal L 229, 15/8/1986 p. 63 DA; Official journal L 220, 20/8/1975 p. 22 DE).
dansk
2009/35/EC Directive 2009/35/EC of the European Parliament and of the Council of 23 April 2009 on the colouring matters which may be added to medicinal products (recast) (Official Journal L 109, 30/4/2009 p. 10-13).
български
češtin
dansk
2009/41/EC Directive 2009/41/EC of the European Parliament and of the Council of 6 May 2009 on the contained use of genetically modified micro-organisms (Recast) (Text with EEA relevance) (OJ L 125, 21.5.2009, p. 75–97)
български
češtin
dansk

EU/469/2009

Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance ) (OJ L 152, 16.6.2009, p. 1–10)

български
češtin
dansk
6/5/1982 Commission Communication on parallel imports of proprietary medicinal products for which marketing authorizations have already been granted (Official Journal C 115, 6/5/1982, p. 5).
COM/2003/839 Commission Communication on parallel imports of proprietary medicinal products for which marketing authorisations have already been granted. [Update of the 1982 Commission Communication](COM/2003/839 final).
dansk
94/C 82/04 Commission Communication 94/C 82/04 on the implementation of the new marketing authorization procedures for medicinal products for human and veterinary use in accordance with Council Regulation (EEC) No 2309/93 of 22 July 1993 and Council Directives 93/39/EEC, 93/40/EEC and 93/41/EEC, adopted on 14 June 1993. (Official Journal C 82, 19/3/1994 p. 4).
dansk
98/C 229/03 Commission communication on the Community marketing authorisation procedures for medicinal products (Official Journal C 229, 22/7/1998 p. 4 - 17).
dansk
 
2004/C 24/06 Note for guidance on minimising the risk of transmitting animal spongiform encephalopathyagents via human and veterinary medicinal products (EMEA/410/01 Rev. 2 - October 2003) adopted by the Committee for Proprietary Medicinal Products (CPMP) and by the Committee for Veterinary Medicinal products (CVMP)
(Official Journal C 24, 2006 p. 6 - 18)
dansk
 
2006/C 133/05 Guideline on the definition of a potential serious risk to public health in the context of Article 29(1) and (2) of Directive 2001/83/EC (Official Journal C 133, 8/6/2006 p. 5 - 7)
češtin
dansk
2008/C 243/09 Guideline on the format and content of applications for agreement or modif ication of a paediatric investigation plan and requests for waivers or deferrals and concerning the operation of the compliance check and on criteria for assessing significant studies
(Official Journal C 243/1, 2008)
български
češtin
dansk
2013/51/EU Commission Implementing Decision of 23 January 2013 on the assessment of a third country’s regulatory framework applicable to active substances of medicinal products for human use and of the respective control and enforcement activities pursuant to Article 111b of Directive 2001/83/EC of the European Parliament and of the Council
български
češtin
dansk


Last update : 20/02/2013